Clinical Trial Update: Study of Pexidartinib in Asian Subjects With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 trial update of pexidartinib in Asian subjects with advanced solid tumors has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• Pexidartinib (pexidartinib)

Snippet

Sponsor: Daiichi Sankyo Co., Ltd. | Conditions: Advanced Solid Tumors | Phase 1 | Status: COMPLETED | Results posted: 2020-04-24